Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
While increasing your time-to-market and product quality.
May 3, 2023
By: Emil W. Ciurczak
Independent Pharmaceuticals Professional
There is a saying in the business world: “You need to spend money to make money.” If you couple this with, “Don’t bring a knife to a gunfight,” you have the beginnings of a path to success for the Pharma manufacturing “guild.” From the largest multi-nationals to the “mom and pop” generics and contract sites, if you spend enough in your lab update/start-up, you will get the best bang for your bucks. Continuing with dusty bromides, our industry can be “penny-wise, but pound foolish.” Ignoring the fact that some companies spend more on marketing than R&D, we are mandated by law to analyze incoming raw materials (excipients, packaging materials, and APIs), intermediate steps (generics need to monitor blending for every lot) and finished products. This takes personnel, lab equipment (and glassware and chemicals), and lots of lab space. Whether you have a world-class or so-so lab is not a lot of dollars or euros different. “Wait!” you might say, “the cost of a ‘world-class’ lab from ‘barely tolerable’ one could be a few hundred percent.” True, if you only bought the equipment, placed the people in the lab, and never touched anything or tried to do an analysis, it would, indeed, be a needless expense. However, while this tableau may make a nice photo for a trade magazine, it doesn’t work for a commercial (working) endeavor. In the real world, many, many samples are generated in production, often at a rapid rate, sent to the lab, prioritized, prepped, analyzed, and results sent to the proper venue (QA, production, etc.) This is where the “worth” versus “price” becomes clear. Price and worth are not the same: think priceless vs. worthless. For example, look at a routine HPLC. The difference between, say, 5 minutes vs. 15 minutes for a result (same sample prep for both, etc.) may not seem much, but I have worked in labs where we made 40-50 lots of the same product, every week! Now, assume the mandated 10-20 units of finished product for each lot, and we have 400 to 1000 HPLC samples of a single product, weekly! Now, for the 15-minute elution time, we have 6,000 to 15,000 minutes of elution time versus 2,000 to 5,000 minutes. Assume a flow rate of between 1-1.5 mL/min and we have 6,000 mL to 22,500 mL of solvent (6 to 22.5 liters of solvent per week for one product). The cost of doing business, you say? I used to think so, too, until I was introduced to UPLC (very high pressure, low flow) chromatography, A few years ago, at one client’s location, while I was waiting for a service rep to perform an IQ/OQ (instrument quality, operational quality) on an NIR (on which I was to do method development), I sauntered to their QC lab, looking for something to do. Their main (virtually only) product analysis method was HPLC: 1.5mL/min for 16 minutes. For those of you slow at math, that’s 24 mL of solvent for each sample injection. Over a year, for a small company, this is both a time-killer and major expense. Using their UPLC (fortunately, they had the same packing as the validated method), I switched the method to 0.6 mL/min for 6 minutes—3.6 mL per injection vs. 24 mL per injection. For 20 samples (one lot), that means 72 mL versus 480 mL per lot! Again, for the math-challenged, that’s 12 minutes for UPLC vs. 320 min (5.3 hours!) waiting for results to pass/fail the batch. Of course, I am ignoring sample prep time, which is for another day. I haven’t mentioned the cost of solvents, yet. It costs to buy them, store them, and legally dispose of them, which often costs more than original purchase price. Using the above example and setting the price for the organic component at let’s say $50 per 4-liter bottle, 20 lots would cost 0.5 liters (UPLC) vs. 9.6 liters (HPLC). That is, one product line, in one week, can use $25 worth of solvent vs. $480 worth. When one considers a moderately large company, the time and cost really adds up quickly. This is not even considering the size of inventory needed to store and possible hazards in storing and moving larger amounts of toxic, flammable solvents. Another area that is a “black hole” for time and personnel is cleaning validation. One of the major driving forces for PAT/QbD is the large percentage of manufacturing equipment not in service at any given time. Depending on the company and product diversity, there may be almost 80 percent of a company’s equipment just sitting, waiting to be cleaned, cleaned and waiting for testing, waiting for test results, and so forth. The most popular (I use that word ironically) method is to swab various positions throughout the unit and send the swabs to the QC lab to be analyzed. We addressed the time involved in the example above. There is always the possibility of proceeding under risk and assuming the equipment was clean, but, since I am assuming honorable companies are reading this, I will suggest a faster, easier way to test for residues. As seen in your local airport and used by TSA to check for explosives, Ion Mobility Spectroscopy is a rapid and specific method to check for residue(s). Simply stated, IMS is a small pseudo mass spectrometer. Figure 1 shows a schematic of an IMS. The sample is placed at the input area, the materials are ionized (radio isotope or electron passage), passes through a grid (ion gate) of the same charge (+ or -) which accelerates it down the column (drift region) to an ion detector. Since each molecule is given the same charge and each has a different mass, the ions move down the drift region in the order of reverse molecular weight. That is, lighter molecules “elute” before more massive ones (see Figure 2).
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !